Tuberculosis is the predominant infection in systemic sclerosis: thirty-year retrospective study of serious infections from a single centre

Rheumatol Int. 2024 Nov;44(11):2505-2515. doi: 10.1007/s00296-024-05688-0. Epub 2024 Aug 24.

Abstract

To look for the spectrum of infections and the factors predisposing to infection in patients with systemic sclerosis (SSc). In this retrospective study, demographic, clinical features, details of infections, immunosuppressive therapy, and outcomes of patients with SSc attending clinics at department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India from 1990 to 2022 were captured. Multivariable-adjusted logistic regression was applied to identify independent predictors of infection. Data of 880 patients, mean age 35.5 ± 12 years, and female: male ratio 7.7:1, were analyzed. One hundred and fifty-three patients had at least 1 infection with a total of 233 infectious episodes. Infections were most common in lung followed by skin and soft tissue. Tuberculosis was diagnosed in 45 patients (29.4%). Klebsiella was the commonest non-tubercular organism in lung and Escherichia coli in urinary tract infections. In comparison to matched control group, patients with infection had a greater number of admissions due to active disease, odds ratio (OR) 6.27 (CI 3.23-12.18), were receiving immunosuppressive medication OR, 5.05 (CI 2.55-10.00), and had more digital ulcers OR, 2.53 (CI 1.17-5.45). Patients who had infection had more likelihood for death OR, 13.63 (CI 4.75 -39.18). Tuberculosis is the commonest infection and lung remains the major site of infection in patients with SSc. Number of hospital admissions, digital ulcers and immunosuppressive therapy are predictors of serious infection in patients with SSc. Patients with infections had more likelihood of death.

Keywords: Digital ulcers; Immunosuppression; Pneumonia; Rodnan skin score; Soft tissue infections; Tuberculosis; Urinary tract infection.

MeSH terms

  • Adult
  • Female
  • Humans
  • Immunosuppressive Agents* / therapeutic use
  • India / epidemiology
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / epidemiology
  • Scleroderma, Systemic* / microbiology
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology
  • Young Adult

Substances

  • Immunosuppressive Agents